16 out of 46 patients in group 1 ( 34.8 % ) , 12 out of 47 in group 2 ( 25.5 % ) and 16 out of 52 in group 3 ( 30.8 % ) had a recurrence of Graves ' disease within 6-year follow-up after drug withdrawal .